Chemoprophylaxis of diabetic nephropathy in the elderly

Drugs and Aging

Volumn 9, Issue 6, 1996, Pages 449-457

  Jungmann, Eckart ^a  

^a Sankt Vinzenz Hospital Rheda Wiedenbruck   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INDAPAMIDE;

AGED; ANTIHYPERTENSIVE THERAPY; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; BODY WEIGHT; CHEMOPROPHYLAXIS; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DRUG CONTRAINDICATION; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEART ARRHYTHMIA; HUMAN; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MICROALBUMINURIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SCREENING;

EID: 0030478226     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199609060-00007     Document Type: Review

References (53)

1. Jungmann E, Usadel KH. Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus. Clin Investig 1992; 70: 942-8
2. Jungmann E, Carlberg C, Schallmayer M, et al. Albuminuria in patients with type 2 diabetes mellitus: impact of blood pressure and metabolic control [in German]. Med Klin 1995; 90: 383-9
3. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995 Oct 21; 346: 1080-4
4. Ritz E. Hypertension in diabetic nephropathy: prevention and treatment. Am Heart J 1993; 125: 1514-9
5. Singh I, Marshall MC. Diabetes mellitus in the elderly. Endocrinol Metab Clin North Am 1995; 24 (2): 255-72
6. United States Renal Data System 1990 Annual Report. Am J Kidney Dis 1990; 16 Suppl. 2: 22-7
7. Viberti JC, Yip-Messent J, Morocutti A. Diabetic nephropathy: future avenue. Diab Care 1992; 15: 1216-25
8. Walker WG, Hermann J, Murphy RP, et al. Prospective study of the impact of hypertension upon kidney function in diabetes mellitus. Nephron 1990; 55 Suppl. 1:21-6
9. Rossing P, Hommel E, Smidt UM, et al. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabelologia 1994; 37: 511-6
10. Wirta O, Pasternack A, Mustonen J, et al. Albumin excretion rate and its relation to kidney disease in non-insulin dependent diabetes mellitus. J Intern Med 1995; 237: 367-73
11. Nelson RG, Pettitt DJ, Baird HR, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 diabetes mellitus in Pima Indians. Diabetologia 1993; 36: 998-1001
12. Schmitz A, Vaeth M, Mogensen CE. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. Diabetologia 1994; 37: 1251-8
13. Schmitz, A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988; 5: 126-34
14. Walker PJ. Chronic complications of diabetes. In: Finucane P, Sinclair AJ, editors. Diabetes in old age. Chichester: John Wiley & Sons, 1995: 107-36
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86
16. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage: the Steno bypothesis. Diabetologia 1989; 32: 219-26
17. Krolewski AS, Laffel LMB, Krolewski M, et al. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1251-5
18. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood glucose control on late complications of type 1 diabetes. Lancet 1993; 341: 1306-9
19. Schmitz A. Renal function changes in middle-aged and elderly Caucasian type 2 diabetic patients - a review. Diabetologia 1993; 36: 985-92
20. UK Prospective Diabetes Study Group: UK Prospective Diabetes Study IX. Relationships of urinary albumin and N-acetylglucosuminidase to glycacmia and hypertension at diagnosis of type 2 diabetes mellitus and after 3 months' diet therapy. Diabetologia 1993; 36: 835-42
21. Schmitz A, Hvid Hansen H, Christensen T. Kidney function in newly diagnosed type 2 diabetic patients, before and during treatment. Diabetologia 1989; 32: 434-9
22. Vora JP, Dolhen J, Williams JD, et al. Impact of initial treatment on renal function in newly-diagnosed type 2 diabetes mellitus. Diabetologia 1993; 36: 734-40
23. Campbell IW, Menzies DG, Chalmers J, et al. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabete Metab 1994; 20: 394-400
24. Jerums G, Murray RML, Seeman E, et al. Lack of effect of gliclazide on early diabetic nephropathy and retinopathy: a two-year controlled study. Diabetes Res Clin Pract 1987; 3: 71-80
25. Wolffenbuttel BHR, van Haeften TW. Prevention of complications in non-insulin-dependent diabetes mellilus (NIDDM). Drugs 1995; 50(2): 263-88
26. Jungmann E, Carlberg C, Schumm-Draeger PM. Impact of glycaemic control on urinary albumin excretion in patients with type 2 diabetes mellitus. Diabetologia 1994; 37: 441-2
27. Randeree HA, Omar MAK, Motala AA, et al. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 1992; 15: 1258-63
28. Tedde R, Sechi LA, Marigliano A, et al. Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens 1989; 2: 163-70
29. Dodson PM, Beevers M, Hallworth R, et al. Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ 1989; 298: 227-30
30. Jungmann E. Diabetic sodium retention |in German|. Nierenund Hochdruckkrh 1992; 21: 709-15
31. Zeller K, Whittaker E, Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78-84
32. Weidmann P, Boehlen LM, de Courten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J 1993; 125: 1498-513
33. Parving HH, Andersen AR, Smidt UM, et al. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 1987; 294: 1443-7
34. Arrauy-Pacheco C, Raskin P. Management of hypertension in diabetes. Endocrinol Metab Clin North Am 1992; 21: 371-94
35. Jungmann E, Krüger K, Semler B, et al. The renoprotective effect of the converting-enzyme inhibitor ramipril in hypertensive patients with insulin-treated type II diabetes mellitus [in German]. Nieren- und Hochdruckkrh 1995; 24: 248-50
36. Anderson S, Renal effects of converting enzyme inhibitors in hypertension and diabetes. J Cardiovasc Pharmacol 1990; 15 Suppl. 3: S11-5
37. Ravid M, Savin H, Jutrin I, et al. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993 Apr 15; 118: 577-81
38. Lewis EJ, Hunsicker LG, Brain KRP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993 Nov 11; 329: 1456-62
39. Kasiske BL, Kalil RSN, Ma ZZ, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-38
40. Heeg JE, De Jong PE, von der Hem GK, et al. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36: 272-9
41. Haller H. Hyperglycaemia and hyperinsulinaemia as important factors in the pathogenesis of diabetic angiopathy. In: Parving HH, editor. The hypertensive diabetic in focus. St Ives: Pope Woodhead & Associates, 1993: 10-20
42. Bakris GL. Hypertension in diabetic patients: an overview of interventional studies to preserve renal function. Am J Hypertens 1993; 6 Suppl. 4: 140S-7S
43. Ruggenenti P, Mosconi L, Bianchi L, et al. Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients. Am J Kidney Dis 1944; 24: 753-63
44. Bretzel RG, Bollen CC, Maeser E, et al. Nephroprotective effects of nitrendipine in hypertensive type 1 and type 2 diabetic patients. Am J Kidney Dis 1993; 21 Suppl. 3: 53-64
45. Jungmann E. Renal action of nitrendipine in normotensive patients with type I diabetes mellitus. Cardiovasc Risk Factors 1994; 4 Suppl. 1: 51-6
46. Haak E, Haak T, Schumm-Draeger PM, et al. Effect of 4-year nitrendipine treatment on microalbuminuria in normotensive patients with type 1 diabetes mellitus |abstract| |in German|. Med Klin 1995; 90 Suppl. II: 77
47. Hoelscher D, Bakris G. Antihypertensive therapy and progression of diabetic renal disease. J Cardiovasc Pharmacol 1994; 23 Suppl. 1: S34-8
48. Stornello M, Valvo EV, Scapellato L. Hemodynamic, renal and humoral effects of the calcium entry blocker nicardipme and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989; 14: 851-5
49. Josefsberg Z, Ross SA, Fick GH, et al. Comparison of nitrendipine and enalapril on the effects of microalbuminuria and metabolic parameters in hypertensive non-insulin-dependent diabetic subjects. In: Parving HH, editor. The hypertensive diabetic in focus. St Ives: Pope Woodhead & Associates. 1993: 40-7
50. Gambardella S, Frontoni S, Felici MG, et al. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria. Am J Cardiol 1990 May 2; 65 Suppl.: 46H-50H
51. Stornello M, Valvo EV, Scapellato L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron 1991; 58: 52-7
52. Nielsen FS, Rossing P, Gall MA, et al. Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 1994; 43: 1108-13
53. Schernthaner G, Schnack C, Hopmeier P. Effect of ramipril or atenolol on microalbuminuria and metabolic control parameters in type-2 diabetes mellitus [abstract]. Diabetologia 1994; 37 Suppl. 1: A195